A graphics card is an essential, and typically expensive, part of a gaming PC. Our picks strike a balance between price and performance — and they’re usually in stock.

Recursion Pharmaceuticals continues to have a pipeline of drugs that might provide further validation for the company's platform. See why I rate RXRX a Sell.

Recursion Pharmaceuticals (RXRX) stock gains as the company plans a 20% workforce reduction to streamline operations and extend cash runway to Q4 2027. Read more here.

Recursion Pharmaceuticals is laying off a fifth of its workforce in connect with a previously announced streamlining of the AI biotech’s pipeline.

MIT and Recursion partner for AI drug discovery tool Freely available Boltz-2 algorithm can predict small-molecule binding affinities by Laura Howes ...

Intel is constantly releasing new versions of its graphic drivers, whether they’re beta versions or official WHQL releases. It’s common to see new drivers almost every week, which is a good ...

Java Development Kit (JDK) 25, a planned long-term support release of standard Java due in September, has reached the initial rampdown or bug-fixing phase with 18 features. The final feature ...

Qualcomm has released security patches for three zero-day vulnerabilities in the Adreno Graphics Processing Unit (GPU) driver that impact dozens of chipsets and are actively exploited in targeted ...

Discover how Alpha Evolve is improving AI with recursive self-improvement, reshaping fields like math, hardware design and efficiency.

The studio is conducting an audit to ensure no other graphics in 'Marathon' were lifted from artists 'without permission or acknowledgement.' ...

Recursion said it will end development for four of its 11 pipeline programs—one of which the company will consider outlicensing to a partner instead—and pause a fifth program, in a pruning ...